ABCELLERA BIOLOGICS INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 2.02 Results of Operations and Financial Condition

On August 12, 2021, AbCellera Biologics Inc., (the "Company"), issued a press release announcing its financial and operational results for the quarter ended June 30, 2021. A copy of the press release is furnished herewith as Exhibit 99.1.

Item 7.01  Regulation FD Disclosure

In connection with its earnings call on August 12, 2021, to discuss its results for the quarter ended June 30, 2021, the Company will utilize a corporate presentation, a copy of which is furnished herewith as Exhibit 99.2.

The information in Items 2.02 and 7.01 of this Form 8-K (including the exhibits attached hereto) is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall such information be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise stated in such filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits


 Exhibit

   No.                                              Description
   99.1            Press Release issued by AbCellera Biologics Inc. on August 12, 2021  .
   99.2            Corporate presentation  .

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses